CN105343593A - Spica prunellae health oral liquid capable of decreasing blood pressure and blood lipid as well as preparation method of spica prunellae health oral liquid - Google Patents
Spica prunellae health oral liquid capable of decreasing blood pressure and blood lipid as well as preparation method of spica prunellae health oral liquid Download PDFInfo
- Publication number
- CN105343593A CN105343593A CN201510755500.0A CN201510755500A CN105343593A CN 105343593 A CN105343593 A CN 105343593A CN 201510755500 A CN201510755500 A CN 201510755500A CN 105343593 A CN105343593 A CN 105343593A
- Authority
- CN
- China
- Prior art keywords
- parts
- spica prunellae
- oral liquid
- hypertension
- health care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 58
- 230000036541 health Effects 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims description 19
- 230000036772 blood pressure Effects 0.000 title abstract description 57
- 239000008280 blood Substances 0.000 title abstract description 43
- 210000004369 blood Anatomy 0.000 title abstract description 42
- 230000003247 decreasing effect Effects 0.000 title abstract description 4
- 150000002632 lipids Chemical class 0.000 title abstract description 3
- 239000003814 drug Substances 0.000 claims abstract description 74
- 206010020772 Hypertension Diseases 0.000 claims abstract description 58
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 73
- 239000000843 powder Substances 0.000 claims description 33
- 229940079593 drug Drugs 0.000 claims description 23
- 201000005577 familial hyperlipidemia Diseases 0.000 claims description 21
- 210000000582 semen Anatomy 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 18
- 230000008901 benefit Effects 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 9
- 229910000831 Steel Inorganic materials 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 238000011068 loading method Methods 0.000 claims description 8
- 238000005325 percolation Methods 0.000 claims description 8
- 239000010959 steel Substances 0.000 claims description 8
- 238000002481 ethanol extraction Methods 0.000 claims description 7
- 238000007654 immersion Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 4
- 235000011613 Pinus brutia Nutrition 0.000 claims description 4
- 241000018646 Pinus brutia Species 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000007598 dipping method Methods 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 235000011837 pasties Nutrition 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 229910001220 stainless steel Inorganic materials 0.000 claims description 4
- 239000010935 stainless steel Substances 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 208000004880 Polyuria Diseases 0.000 abstract description 15
- 230000035619 diuresis Effects 0.000 abstract description 15
- 210000004204 blood vessel Anatomy 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 9
- 239000003053 toxin Substances 0.000 abstract description 7
- 231100000765 toxin Toxicity 0.000 abstract description 7
- 108700012359 toxins Proteins 0.000 abstract description 7
- 230000007246 mechanism Effects 0.000 abstract description 6
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract description 3
- 230000001939 inductive effect Effects 0.000 abstract description 3
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract description 2
- 240000001341 Reynoutria japonica Species 0.000 abstract 2
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 2
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 1
- 241000092668 Artemisia capillaris Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000123865 Gynura bicolor Species 0.000 abstract 1
- 240000001638 Scurrula parasitica Species 0.000 abstract 1
- 240000006688 Telosma cordata Species 0.000 abstract 1
- 235000017352 Telosma cordata Nutrition 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 39
- 210000004185 liver Anatomy 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 230000008961 swelling Effects 0.000 description 20
- 230000001737 promoting effect Effects 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 17
- 230000036407 pain Effects 0.000 description 17
- 206010062717 Increased upper airway secretion Diseases 0.000 description 16
- 208000026435 phlegm Diseases 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 206010012601 diabetes mellitus Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 14
- 206010030113 Oedema Diseases 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 230000001077 hypotensive effect Effects 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 13
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 230000002045 lasting effect Effects 0.000 description 12
- 201000007227 lymph node tuberculosis Diseases 0.000 description 12
- 206010019233 Headaches Diseases 0.000 description 11
- 231100000869 headache Toxicity 0.000 description 11
- 239000003440 toxic substance Substances 0.000 description 11
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 10
- 208000002173 dizziness Diseases 0.000 description 10
- 229940096998 ursolic acid Drugs 0.000 description 10
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 10
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 9
- 108091006146 Channels Proteins 0.000 description 9
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 9
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 9
- 206010023126 Jaundice Diseases 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 9
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 230000004438 eyesight Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 229940100243 oleanolic acid Drugs 0.000 description 9
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 210000000232 gallbladder Anatomy 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 7
- 241000628997 Flos Species 0.000 description 7
- 206010018498 Goitre Diseases 0.000 description 7
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 7
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 7
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 description 7
- 229940074360 caffeic acid Drugs 0.000 description 7
- 235000004883 caffeic acid Nutrition 0.000 description 7
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 150000002338 glycosides Chemical class 0.000 description 7
- 201000003872 goiter Diseases 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 7
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 7
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 7
- 229960004555 rutoside Drugs 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 6
- 239000004072 C09CA03 - Valsartan Substances 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 6
- 230000034994 death Effects 0.000 description 6
- 239000002934 diuretic Substances 0.000 description 6
- 230000001882 diuretic effect Effects 0.000 description 6
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 231100000252 nontoxic Toxicity 0.000 description 6
- 230000003000 nontoxic effect Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 6
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 6
- 235000005493 rutin Nutrition 0.000 description 6
- SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 description 6
- 229960004699 valsartan Drugs 0.000 description 6
- LHXDLQBQYFFVNW-XCBNKYQSSA-N (+)-fenchone Chemical compound C1C[C@]2(C)C(=O)C(C)(C)[C@H]1C2 LHXDLQBQYFFVNW-XCBNKYQSSA-N 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010010726 Conjunctival oedema Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 101100426589 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) trp-3 gene Proteins 0.000 description 5
- 102000003629 TRPC3 Human genes 0.000 description 5
- 102000003623 TRPC6 Human genes 0.000 description 5
- 108050001421 Transient receptor potential channel, canonical 6 Proteins 0.000 description 5
- 101150037542 Trpc3 gene Proteins 0.000 description 5
- -1 amaroid Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000000916 dilatatory effect Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000002526 effect on cardiovascular system Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 230000001631 hypertensive effect Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 159000000000 sodium salts Chemical class 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000007530 Essential hypertension Diseases 0.000 description 4
- LHXDLQBQYFFVNW-UHFFFAOYSA-N Fenchone Chemical compound C1CC2(C)C(=O)C(C)(C)C1C2 LHXDLQBQYFFVNW-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 4
- 229960000528 amlodipine Drugs 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 208000002894 beriberi Diseases 0.000 description 4
- 235000005473 carotenes Nutrition 0.000 description 4
- 150000001746 carotenes Chemical class 0.000 description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 238000010253 intravenous injection Methods 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 235000018553 tannin Nutrition 0.000 description 4
- 239000001648 tannin Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 4
- 229930006731 (1S,4R)-fenchone Natural products 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 229930040373 Paraformaldehyde Natural products 0.000 description 3
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 3
- 102000027549 TRPC Human genes 0.000 description 3
- 108060008648 TRPC Proteins 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000007336 cyanidin Nutrition 0.000 description 3
- 235000007242 delphinidin Nutrition 0.000 description 3
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 150000002887 oleanolic acids Chemical class 0.000 description 3
- 229920002866 paraformaldehyde Polymers 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 229930182493 triterpene saponin Natural products 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010015958 Eye pain Diseases 0.000 description 2
- 206010060710 Galactostasis Diseases 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 2
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 241000195474 Sargassum Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 108010037150 Transient Receptor Potential Channels Proteins 0.000 description 2
- 102000011753 Transient Receptor Potential Channels Human genes 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229960004005 amlodipine besylate Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 210000002376 aorta thoracic Anatomy 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 239000010238 camphora Substances 0.000 description 2
- 229940025250 camphora Drugs 0.000 description 2
- 150000003943 catecholamines Chemical class 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 2
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 229930006735 fenchone Natural products 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002633 protecting effect Effects 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 2
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 2
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 206010038464 renal hypertension Diseases 0.000 description 2
- 230000036454 renin-angiotensin system Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000002889 sympathetic effect Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical group N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- VHOCUJPBKOZGJD-UHFFFAOYSA-N triacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000011706 wistar kyoto rat Methods 0.000 description 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- 101150059573 AGTR1 gene Proteins 0.000 description 1
- 102100030841 AT-rich interactive domain-containing protein 4A Human genes 0.000 description 1
- 241000199899 Alariaceae Species 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 108091005462 Cation channels Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102100033902 Endothelin-1 Human genes 0.000 description 1
- 101800004490 Endothelin-1 Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 101000792933 Homo sapiens AT-rich interactive domain-containing protein 4A Proteins 0.000 description 1
- 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 102100036721 Insulin receptor Human genes 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241001466452 Laminariaceae Species 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000219304 Portulacaceae Species 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 101000693619 Starmerella bombicola Lactone esterase Proteins 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000032594 Vascular Remodeling Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003986 cell retinal photoreceptor Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000019628 coolness Nutrition 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000021471 food effect Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 229930187479 gypenoside Natural products 0.000 description 1
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000013115 immunohistochemical detection Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 235000021142 long-term diet Nutrition 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940036132 norvasc Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 description 1
- 229960003401 ramipril Drugs 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008060 renal absorption Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008700 sympathetic activation Effects 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- QZZGJDVWLFXDLK-UHFFFAOYSA-N tetracosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 229940043102 valsartan and amlodipine Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a spica prunellae health oral liquid capable of decreasing blood pressure and blood lipid. The spica prunellae health oral liquid is prepared from the following raw materials in parts by weight: 10-50 parts of spica prunellae, 10-20 parts of corn stigma, 10-20 parts of gynura bicolor, 10-20 parts of loranthus parasiticus, 10-20 parts of cassia seeds, 10-20 parts of gynostemma pentaphylla, 10-20 parts of folium mori, 10-20 parts of herba portulacae, 10-20 parts of kelp, 10-20 parts of prepared fleece flower root, 10-20 parts of polygonum cuspidatum, 10-20 parts of hawthorn fruits, 10-20 parts of radix scutellariae, 10-20 parts of sculellaria barbata, 10-20 parts of rhizoma alismatis, 10-20 parts of capillary Artemisia, 10-20 parts of fructus gardeniae, and 10-20 parts of Chinese violet. The traditional Chinese medicine blood-pressure-decreasing tea solves the hypertension problem fundamentally, which is different from the Western medicine which only temporarily decreases blood pressure and improves the symptoms by expanding blood vessels. The spica prunellae health oral liquid has the mechanism of decreasing blood pressure as follows: reducing fat, freeing vessels, softening blood vessels, inducing diuresis, expelling toxins, and reducing blood pressure.
Description
Technical field
The present invention relates to the health product containing deriving from plant composition, particularly a kind of Spica Prunellae health care oral liquid and preparation method thereof of hypertension and hyperlipemia.
Background technology
Day by day flourishing due to economy, the continuous lifting of modern's living standard, cause people too much have deep love for enjoy, do not notice that the life style of oneself, behavioural habits, diet are had a liking for, thus the disease caused.Society with fast rhythm lives, the operating pressure of keen competition, serious threat is caused to the physical and mental health of modern, add that long-term diet is unreasonable, that is: smart grain replaces coarse grain completely, the pesticide remained in the absorption of a large amount of three-hypers (high heat, high protein, higher fatty acid), more than three (antiseptic is many, flavour enhancer is many, hormone many) food and food, chemical fertilizer stockpiling in vivo, add air, pollution of waterhead and quantity of motion less than normal, obesity and hypertensive diabetes have just become the affluenza of city gang.
Hypertension is the important risk factor causing heart disease, cerebrovascular, nephropathy to occur and develop, and is the modal chronic disease of global human.China's prevalence of hypertension rate sustainable growth, the death that cardiovascular and cerebrovascular disease causes has been positioned at first of the cause of death of China resident, becomes the major disease threatening China's residents ' health.The generation of cardiovascular and cerebrovascular disease with develop over half relevant with hypertension, therefore effectively controlling hypertension is the key preventing cardiovascular and cerebrovascular disease.In hypertension, more than 95% is essential hypertension, and the pathogenesis of essential hypertension is complicated, illustrates not yet completely so far.Think multifactor coefficient result at present, h and E factor is mainly through following approach regulation and control blood pressure: the retention of sodium salt kidney, inner skin cell function imbalance, sympathetic nervous system, renin-angiotensin system (rennin-angiotensinsystem, RAS), insulin resistant etc.
The final purpose of Treatment of Hypertension reduces hyperpietic's heart, the incidence rate of cerebrovascular and mortality rate.Treatment of Hypertension should establish controlling of blood pressure desired value.On the other hand, hypertension usually merges with the risk factor of other hearts, cerebrovascular and exists, such as hypercholesterolemia, obesity, diabetes etc., collaboratively increases the weight of cardiovascular disease risk, and remedy measures should be comprehensive.1. behavior of making the life better loses weight.2. reduce sodium salt to take in.3. calcium and potassium salt is supplemented.4. fat intake is reduced.5. motion is increased.6. give up smoking, limit and drink.
Spica Prunellae is the dry fruit ear of labiate Spica Prunellae PrunellavulgarisL..All parts of the country are all produced, main product in Jiangsu, Zhejiang, Anhui, the ground such as Henan.Gather when summer, fruit ear was brownish red, removing impurity, dries.Raw use.Its property is pungent, bitter, cold.Return liver, gallbladder meridian.There is clearing away heat-fire, improving eyesight, effect of mass dissipating and swelling eliminating.
Treatment conjunctival congestion and swelling pain, dizzy, order pearl nyctalgia of having a headache.Spica Prunellae bitter cold master enters Liver Channel, and kind removing fire from the liver is with improving eyesight.With controlling flaming up of liver-fire, conjunctival congestion and swelling pain, it is medicinal to join Folium Mori, Flos Chrysanthemi, Semen Cassiae etc.Among this product liver heat removing and eyesight improving, nourishing the liver of slightly holding concurrently, joins Radix Angelicae Sinensis, Fructus Lycii, can be used for deficiecny of liver-YIN, ophthalmalgia, to night more particularly; Also can accessory stick up, Radix Glycyrrhizae use, as loose in Spica Prunellae (" Zhang Shi doctor is logical ").
Treatment scrofula, goiter.This product acrid in the mouth energy eliminating stagnation, bitter cold can expel the heat-evil, and it is medicinal to control pathogenic fire derived from stagnation of liver-QI often to join Bulbus Fritillariae Uninbracteatae, Fructus Forsythiae etc., and the scrofula of phlegm-fire cohesion, as Spica Prunellae soup (" Waike Zhengzong, Orthodox Manual of External Diseases "); With controlling goiter, then often join the use such as Thallus Laminariae (Thallus Eckloniae), Radix Scrophulariae, as Spica Prunellae cream (Golden Mirror of Medicine).
Treatment acute mastitis swells and ache.This product heat clearing away can go liver-fire, again can mass dissipating and swelling eliminating, can control acute mastitis and swell and ache, normal with Herba Taraxaci with (" book on Chinese herbal medicine converges and says ").If join Flos Lonicerae, pathopyretic ulcer can be controlled, as detoxicating pill (" blue or green capsule is secretly handed down ").
Shennong's Herbal carries it: " main cold and heat, scrofula, scrofula, head sore, broken disease.Loose wart stagnation of QI, swelling of the feet arthralgia chiefly caused by damp pathogen." Compendium of Material Medica carries it: " Spica Prunellae controls ophthalmalgia, and with Saccharum Sinensis Roxb. water logging one ight, get it and can separate interior-heat, slow liver-fire is also.Lou Quan is apt to cloud, Spica Prunellae control order pearl pain to night then notably, the magical effect, or with bitter cold snack made with traditional Chinese medicines instead notably, the also magical effect.Lid order pearl connects order originally, and liver system also, belongs to the warp of the moon of fainting.Night very and some bitter and cold medicines anti-notably, night is with cold also cloudy therefore also.The gas of the pure sun of summer withered official report, mends cloudy blood vessels of fainting, therefore controls this as god, with Yang Zhiyin also." " notes of Chongqing hall " sub " grass, micro-pungent and sweet, therefore among eliminating stagnation, have the merit with positive yin nourishing concurrently, namely what after losing blood, the person of being insomnia took sleeps, and its property is visible.Chen Jiuzhe is especially sweet, is used as medicine for victory.”
Pharmacological research
1. chemical composition: this product is containing organic acid such as the glycoside materials such as triterpene saponin, rutin, hyperin and ursolic acid, caffeic acid, free oleanolic acids; Containing the anthocyanin, d-Camphora, d-fenchone etc. of delphinidin, cyanidin in spica.
2. pharmacological action: this product decoct, water-leach liquor, alcohol-water leachate and alcohol leaching liquid all can obviously reduce laboratory animal blood pressure, and stem, leaf, fringe and herb all have hypotensive effect, but the effect of fringe is more obvious; This product water decoction-alcohol sedimentation liquid mouse peritoneal is injected, and has obvious antiinflammatory action; This product decoct all has certain inhibitory action to dysentery bacterium, Bacillus typhi, vibrio cholera, escherichia coli, Bacillus proteus, staphylococcus and Bacillus tuberculosis in vitro.
3. clinical research: combine and be used for the treatment of headache, dizzy traditionally, pharmacological research has hypotensive activity, and modern clinic, in order to Hypertension, helps blood pressure lowering; Get its mass dissipating and swelling eliminating and conventional control the person that belongs to liver-heat such as thyromegaly, lymphadenectasis, cyclomastopathy, hypertension; With Spica Prunellae, Herba Hedyotidis Diffusae, Rhizoma Imperatae, Radix Glycyrrhizae, Radix Isatidis, Radix Sophorae Tonkinensis, be decocted in water for oral dose, Treatment chronic Hepatitis B 50 example, cures 33 examples, and take a turn for the better 12 examples; With Spica Prunellae, Pseudobulbus Bletillae (Rhizoma Bletillae), grind to the powder altogether, Adeps Sus domestica adjusts cream to apply affected part, controls rhagadia manus et pedis 36 example, recovery from illness 34 example; Use Spica Prunellae 100g, decocting 2 times, foam washing both hands, treatment hand desquamation demonstrate,proves over one hundred example, all fully recovers.
Spica Prunellae compatibility Radix Angelicae Sinensis, Radix Paeoniae Alba Spica Prunellae liver heat removing scattered silt; Radix Angelicae Sinensis, the Radix Paeoniae Alba nourish blood and enrich blood. and three's compatibility separates stagnation of liver-QI with having, effect of nourishing the liver blood is used for the treatment of all diseases caused by hepatic depression and blood deficiency.
Spica Prunellae compatibility Flos Chrysanthemi Spica Prunellae clearing away liver-fire, suppressing the hyperactive liver sun; The cool liver of Flos Chrysanthemi heat clearing away. Papillary have liver heat removing, cool liver, suppressing the hyperactive liver merit is used for the treatment of flaming up of liver-fire, wind-heat of liver channel causes conjunctival congestion and swelling pain; Or the headache, dizzy that excessive rising of liver-YANG causes.
Spica Prunellae compatibility Thallus Laminariae (Thallus Eckloniae), Sargassum Spica Prunellae clearing away liver-fire Disperse hepatic depression; Thallus Laminariae (Thallus Eckloniae), the equal eliminating phlegm and softening indurated mass of Sargassum and diuretic.Three medicines have share eliminating stagnation of relieving inflammation or internal heat, effect of eliminating phlegm and softening indurated mass is used for the treatment of the caused scrofula of liver-fire expectorant knot.
Spica Prunellae compatibility Radix Scrophulariae, Fructus Forsythiae Spica Prunellae clearing away liver-fire and Disperse hepatic depression; Radix Scrophulariae quench eliminating stagnation; Fructus Forsythiae detoxicating and resolving stagnation of pathogens. three is with strengthening the scrofula being used for the treatment of phlegm-fire and tying mutually by the power of its eliminating stagnation of relieving inflammation or internal heat.Modern selects some health foods or functional food to be in order to building body.The function of health product mainly improves blood circulation of human body, enriching yin and nourishing kidney, to reach hypoglycemic blood pressure lowering; Improve the effect of body immunity.The various health product sold on the market now, dragons and fishes jumbled together for medicine, and the amusement of great majority just false propaganda, what have does not only have health-care components, also causes the huge injury of the person.Chinese medicine odor is poor, and a lot of people is reluctant long-term taking; Even if take, be medicine three points of poison, allow during people's long-term taking and also produce resisting psychology.Chinese medicine blood pressure lowering tea of the present invention solves hypertension problem from basic, is that temporary the reducing blood pressure of blood vessel dilating improves symptom, the mechanism of blood pressure lowering of the present invention: fat eliminating unlike Western medicine, promote blood circulation, vessel softening, diuresis, toxin expelling, decompression is that the basic reason produced from hypertension is started with, blood pressure lowering is very lasting, and, the dizziness that the Western medicine simultaneously can also eliminating hypertension and blood pressure lowering brings, headache, feel sick, inappetence, the malaise symptoms such as edema.Chinese medicine blood pressure lowering curative effect is lasting, and safety is reliably, nontoxic, is worth stand energetically wide.
Summary of the invention
Technical problem to be solved by this invention is, Western medicine is that temporary the reducing blood pressure of blood vessel dilating improves symptom, the mechanism of blood pressure lowering of the present invention: fat eliminating, promote blood circulation, vessel softening, diuresis, toxin expelling, decompression is that the basic reason produced from hypertension is started with, blood pressure lowering is very lasting, the dizziness that the Western medicine simultaneously can also eliminating hypertension and blood pressure lowering brings, headache, feels sick, inappetence, the malaise symptoms such as edema.Chinese medicine blood pressure lowering curative effect is lasting, and safety is reliably, nontoxic, is worth promoting.Chinese medicine odor is poor, and a lot of people is reluctant long-term taking; Even if take, be medicine three points of poison, allow during people's long-term taking and also produce resisting psychology.Spica Prunellae is sweet in flavor and cold in property, enters lung, liver, kidney channel.Property get a breathing space and, can rise and can fall.Can invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling.These product have hypotensive effect again, are usually used in hypertension clinically in recent years.The micro-bitter glycol of the present invention; Add some blood circulation promoting and blood stasis dispelling, mouthfeel is light, does not destroy the Chinese medicine of Spica Prunellae taste, does not affect mouthfeel, makes people be easy to accept, can reach effect of hypertension and hyperlipemia preferably.
For solving above-mentioned technical barrier, the invention provides a kind of Spica Prunellae health care oral liquid of hypertension and hyperlipemia, described in it, Spica Prunellae health care oral liquid comprises the raw material of following parts by weight: Spica Prunellae 10 ~ 50 parts, Stigma Maydis 10 ~ 20 parts, Radix Semiaquilegiae 10 ~ 20 parts, Herba Taxilli 10 ~ 20 parts, Semen Cassiae 10 ~ 20 parts, Herb Gynostemmae Pentaphylli 10 ~ 20 parts, 10 ~ 20 parts, Folium Mori, Herba Portulacae 10 ~ 20 parts, Thallus Laminariae (Thallus Eckloniae) 10 ~ 20 parts, Radix Polygoni Multiflori Preparata 10 ~ 20 parts, Rhizoma Polygoni Cuspidati 10 ~ 20 parts, Fructus Crataegi 10 ~ 20 parts, Radix Scutellariae 10 ~ 20 parts, Herba Scutellariae Barbatae 10 ~ 20 parts, Rhizoma Alismatis 10 ~ 20 parts, Herba Artemisiae Scopariae 10 ~ 20 parts, Fructus Gardeniae 10 ~ 20 parts, Herba Violae 10 ~ 20 parts.
The Spica Prunellae health care oral liquid of described hypertension and hyperlipemia, described in it, Spica Prunellae health care oral liquid can comprise the raw material of following parts by weight: Spica Prunellae 10 ~ 30 parts, Stigma Maydis 10 ~ 15 parts, Radix Semiaquilegiae 10 ~ 15 parts, Herba Taxilli 10 ~ 15 parts, Semen Cassiae 10 ~ 15 parts, Herb Gynostemmae Pentaphylli 10 ~ 15 parts, 10 ~ 15 parts, Folium Mori, Herba Portulacae 10 ~ 15 parts, Thallus Laminariae (Thallus Eckloniae) 10 ~ 15 parts, Radix Polygoni Multiflori Preparata 10 ~ 15 parts, Rhizoma Polygoni Cuspidati 10 ~ 20 parts, Fructus Crataegi 10 ~ 20 parts, Radix Scutellariae 10 ~ 20 parts, Herba Scutellariae Barbatae 10 ~ 20 parts, Rhizoma Alismatis 10 ~ 20 parts, Herba Artemisiae Scopariae 10 ~ 20 parts, Fructus Gardeniae 10 ~ 20 parts, Herba Violae 10 ~ 20 parts.
The Spica Prunellae health care oral liquid of described hypertension and hyperlipemia, described in it, Spica Prunellae health care oral liquid can also comprise the raw material of following parts by weight: Spica Prunellae 10 ~ 50 parts, Stigma Maydis 10 ~ 20 parts, Radix Semiaquilegiae 10 ~ 20 parts, Herba Taxilli 10 ~ 20 parts, Semen Cassiae 10 ~ 20 parts, Herb Gynostemmae Pentaphylli 10 ~ 20 parts, 10 ~ 20 parts, Folium Mori, Herba Portulacae 10 ~ 20 parts, Thallus Laminariae (Thallus Eckloniae) 10 ~ 20 parts, Radix Polygoni Multiflori Preparata 10 ~ 20 parts, Rhizoma Polygoni Cuspidati 10 ~ 15 parts, Fructus Crataegi 10 ~ 15 parts, Radix Scutellariae 10 ~ 15 parts, Herba Scutellariae Barbatae 10 ~ 15 parts, Rhizoma Alismatis 10 ~ 15 parts, Herba Artemisiae Scopariae 10 ~ 15 parts, Fructus Gardeniae 10 ~ 15 parts, Herba Violae 10 ~ 15 parts.
For solving the problems of the technologies described above, the present invention also provides a kind of preparation method of Spica Prunellae health care oral liquid of hypertension and hyperlipemia, and described in it, the preparation process of Spica Prunellae health care oral liquid comprises following aspect:
A. gather when Spica Prunellae fruit ear is brownish red when summer, removing impurity, dries, raw use;
B. the Spica Prunellae dried is pulverized, soaked ethanol heating extraction;
C. by other raw material pulverizing described, immersion ethanol extraction;
D. mixed by other raw material extracting solution concentrated with the Spica Prunellae extracting solution prepared, sterilizing is prepared into oral solutions.
In described step a, can between the 6-8 month, when Spica Prunellae fruit ear is brownish red, harvesting, dry in the sun, allow it parch, for subsequent use.
In described step b, Spica Prunellae chopping can be placed in 70-90% ethanol and soak 1-2 hour, in water-bath, be heated to 60 DEG C-70 DEG C, lixiviate 2h, every 10min stirs once, by filtered through gauze, adds 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, every 10min stirs once, filtered through gauze, merges lixiviating solution, be condensed into pasty state filtrate, stand-by.
In described step c, all the other raw materials can be cleaned roguing, put into 10 times amount ethanol, soak 1-2 hour, heating extraction 2 times, each 1-2 hour, remove supernatant, merge extractive liquid, 100-120 order filters, be the ultrafiltration post ultrafiltration of 5000-10000 again through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.05 filtrate.
In described steps d, two kinds of extracting solution can be inserted in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C, relative density is the concentrated solution of 1.25, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.1g crude drug amount, bottles after ultraviolet ray sterilization bactericidal.
For solving the problems of the technologies described above, the present invention also provides a kind of preparation method of Spica Prunellae health care oral liquid of hypertension and hyperlipemia, and the preparation process of described Spica Prunellae health care oral liquid also comprises following aspect:
A. gather when Spica Prunellae fruit ear is brownish red when summer, removing impurity, dries, raw use;
B. the Spica Prunellae dried pulverizing, immersion ethanol are added extraction heat;
C. by other raw material pulverizing described, immersion ethanol extraction;
D. mixed by other raw material extracting solution concentrated with the Spica Prunellae extracting solution prepared, sterilizing is prepared into oral solutions.
In described step b, the extraction step of Spica Prunellae can be: get Spica Prunellae chopping for subsequent use, steep in the ethanol of 5-10 times amount, be equipped with by medicated powder in lid stainless steel cask, add 70% ethanol, quality is 0.8-1 times of coarse powder, stir, moistening airtight placement more than 1 hour, makes abundant expansion; Drug sample after moistening expansion is mixed pine by filter plate gauze bag parcel again bottom percolator after paving does loose, then powder is contained with rustless steel spoon, uniform loading percolator, dress 10-12 cm thick, even by T-bar pressure, then press aforesaid operations, loading in layer, suitable pressurization, medicated powder must not load 2/3 eminence exceeding percolator; Medicated powder face upper cover rustless steel orifice plate fastens, and opens the baiting valve below percolator, and puts a container, then slowly add 70% ethanol; Air between medicated powder powder to be discharged, and have ethanol to flow out about about 20L, close baiting valve, cover cylinder of filtering, dipping 24 hours, then open baiting valve and carry out percolation, control percolation speed and be generally 1000g medical material outflow 2 ~ 3ml per minute, filtrate puts into liquid container, and pours ethanol time emptying into liquid container; Percolate is merged and leaves standstill.
Chinese medicine blood pressure lowering of the present invention solves hypertension problem from basic, is that temporary the reducing blood pressure of blood vessel dilating improves symptom, the mechanism of blood pressure lowering of the present invention: fat eliminating unlike Western medicine, promote blood circulation, vessel softening, diuresis, toxin expelling, decompression is that the basic reason produced from hypertension is started with, blood pressure lowering is very lasting, the dizziness that the Western medicine simultaneously can also eliminating hypertension and blood pressure lowering brings, headache, feels sick, inappetence, the malaise symptoms such as edema.Chinese medicine health-care oral liquid blood pressure lowering curative effect is lasting, and safety is reliably, nontoxic, is worth promoting.Health care oral liquid is applicable to daily drinking, and blood pressure lowering curative effect is lasting, and safety is reliably, nontoxic, is worth promoting.
Detailed description of the invention
Most of hypertension case does not have the single or specific cause of disease, and this situation is considered to idiopathic, and be the interactional result of h and E, hereditation is within the scope of 30%-60% according to estimates.Essential hypertension majority is polygenes dysfunction, and wherein each gene pairs blood pressure has sub-fraction effect.Environmental factors certainly plays a role, and the interaction of itself and several genes can make blood pressure tilt distribution be offset to higher level.H and E factor, by what approach raising blood pressure, is illustrated at present not yet completely.From blood pressure aerodynamic point, blood pressure=heart output × Peripheral resistance, therefore, the factor affecting these two aspects all take part in hypertensive generation, comparatively concentrates on following link: 1) the kidney retention of sodium salt, and too much sodium salt is by renal reabsorption, circulation volume increases, body makes excessive tissue pour into for avoiding cardiac output to increase, and SR small artery shrinks and strengthens, and peripheral vascular resistance increases.2) inner skin cell function imbalance, endotheliocyte is considered to the source that material is shunk in multiple diastole, the smooth muscle cell below it is had to the paracrine impact of local.The vasodilator reaction mediated as nitric oxide (nitrogenmonoxidum, NO) is impaired may promote abnormal vascular remodeling; Endothelin-1 can cause strong and lasting vasoconstriction, and its receptor blocking agent can improve the endothelium-dependent vasodilatation of hyperpietic.3) sympathetic activity is hyperfunction, and sympathetic activation patient catecholamine levels raises, by separately or with the synergism that catecholamine stimulates renin release, shrink small artery, increase heart output or change normal kidney pressure volume relationship.4) renin-angiotensin system, the all functions of feritin are all completed by synthesis AngII, AngII and angiotensinconverting enzyme (angiotensinII1typereceptor, AT1R) combine, direct contraction small artery, and by stimulating Aldosterone Secretion to increase circulating blood volume.5) insulin resistant, insulin resistant is the common pathophysiological basis that type 2 diabetes mellitus and hypertension occur, and insulin resistant causes Secondary cases hyperinsulinemia, makes sympathetic activity hyperfunction, and can increase kidney sodium salt and heavily absorb.
In the Chinese ten large causes of death, the mortality rate relevant to metabolic disease is just up to 35.7%, and the death toll relevant to " three-hypers " also accounts for 27% of total death toll.Hyperlipidemia can cause blood vessel embolism; Hypertension can cause cerebral hemorrhage and rupture of blood vessel in brain; Hyperglycemia can cause diabetes.World Health Organization (WHO) once clearly proposed, and prevented the first line of defence of cardiovascular diseases from reducing " three-hypers " exactly and controlling " three-hypers ".A lot of diabetes patient is with hyperlipemia, and therefore diabetes and hyperlipemia, people call that sister is sick usually, and think that hyperlipidemia is the secondary disease of diabetes.The diabetic of about 40% has disorders of lipid metabolism according to statistics.Be characterized in that triglyceride increases to reduce with high density lipoprotein.When the reason that diabetes cause blood fat to increase is due to diabetes patient's insufficient insulin, body lactonase activity lowers, and therefore easily blood fat increases.Diabetes itself also accompany fat, protein and water, dielectric disorder except carbohydrate metabolism disturbance simultaneously on the other hand.Often there is free fatty to mobilize out from fat depot, triglyceride and FFA concentrations in blood are increased.Type 2 diabetes mellitus people takes food too much on the one hand again, and motion is few, and impel lipid synthesis in body to increase, this is also the reason causing blood fat to increase.And fat companion's hyperlipidemia person, because Insulin receptor INSR number reduces relatively, thus produce insulin resistant, easy induced Diabetic.Blood fat increased perosn also easily causes the heart, cerebrovascular complication.
The triterpene saponin that it is aglycon that Spica Prunellae herb contains with oleanolic acid (Oleanolicacid).Still containing the glycoside material such as rutin (Rutin), hyperin (Hyperoside). also containing organic acid such as ursolic acid (Ursolicacid), caffeic acid (Caffeicacid) and free oleanolic acids. still containing inorganic salts such as vitamin B1, vitamin C, vitamin K, carotene, resin, amaroid, tannin, volatile oil, alkaloid and potassium chloride.
The anthocyanin of delphinidin (Delphinidin) and cyanidin (Cyanidin) is contained in spica, d-Camphora (d-Camphor), d-fenchone (d-Fenchone), ursolic acid, fruit ear is containing ursolic acid (ursolicacid), oleanolic acid (oleanolicacid), ursolic acid and oleanolic acid are the Saponin of main glycoside unit, daucosterol (daucosterol), β-Amyrin (β-mayrin) and its lignoceric acid (tetra-cosanicacid), 20 produce alkanoic acid (hexacosanicacid), the ester of octocosoic acid (octa-cosanicacid) and melissic acid (triacontanicacid).
Herb is containing acidity many grain Polysaccharides from Prunella vulgaris L (prunellin) of tool anti human immune deficiency virus (HIV), also containing oleanolic acid, ursolic acid, oleanolic acid is the Saponin of glycoside unit, globulariacitrin (rutin), hyperin (hyperoside), caffeic acid (caffeicacid), vitamin (vitamins) C, D, D carotene (carotene), tannin (tan-nin), and thing sense (alkaloids) and volatile oil, wherein containing levo-camphor (camphor), dextrorotation fenchone (fenchone).
Modern study
To the effect of cardiovascular system
Spica Prunellae decoct (concentration is 1: 10 ten thousand ~ 1: 100 ten thousand) can make Cor Leporis in place and isolated frog heart shrinkage amplitude increase, but concentration increase (1: 20 ~ 1: 50) then makes shrinkage amplitude diminish.
The water-leach liquor of Spica Prunellae, ethanol water-leach liquor and 30% ethanol extraction, to anesthetized animal lumbar injection, intravenous injection or the oral effect that all reduces blood pressure, intravenous injection hypotensive effect is obvious, oral administration then hypotensive effect is faint. and decoct (100mg/kg) is injected in anesthetized dog, significantly lasting hypotensive effect can be produced, but there is tachylaxis, after vagotomy, its hypotensive effect obviously weakens. to renal hypertension dog, after taking medicine continuously 2 weeks, blood pressure has moderate reduction, returns to again originally level after drug withdrawal.Spica Prunellae stem, leaf, fringe and herb all have hypotensive effect, and the effect of fringe is more weak.
Resisting pathogenic microbes effect experiment in vitro shows: Spica Prunellae decoct all has certain inhibitory action to dysentery bacterium, Bacillus typhi, vibrio cholera, escherichia coli, Bacillus proteus, bacillus pyocyaneus and staphylococcus, streptococcus and Bacillus tuberculosis.
Spica Prunellae can make the pulmonary lesion of the sick mice of experimental M alleviate to some extent.Spica Prunellae fresh goods is squeezed the juice and is all had inhibitory action to staphylococcus aureus, beta hemolytic streptococcus, escherichia coli, Bacillus typhi, dysentery bacterium, diphtheria corynebacterium, anthrax bacillus, bacillus pyocyaneus.
Water logging agent (1: 4) is also had inhibitory action in various degree to permitting some common pathogenic dermatophytes such as blue achorion, Du's big belly microspore achorion difficult to understand in vitro.
Immunosuppressive action
Experiment shows: Spica Prunellae injection 6g (crude drug)/kg subcutaneous injection, can make Cavia porcellus, mice adrenal gland obviously increases, the obvious atrophy of thymus, spleen.Spica Prunellae water decoction-alcohol sedimentation liquid (1: 1) intramuscular injection 3g (crude drug)/kg, can make adult rat adrenal tissue weight increase, and Thymus and spleen weight saving, the wherein remarkable atrophy of thymus, compared with matched group, on average alleviates 63.4%.In addition, the organizational structure of adrenal cortex, thymus and spleen still can be made to change to some extent.
Spica Prunellae decoct (1: 50 ~ 1: 200) can make rabbit isolated uterine occur tetanic contraction.To isolated rabbit intestinal, high concentration can strengthen it and wriggle, and the most responsive with duodenum, ileum sensitivity is poor.Once had report, 100% Spica Prunellae decoct can suppress the growth of mice S180 and ehrlich carcinoma, but the anti-more not administration group of mortality rate is higher.
Spica Prunellae water decoction-alcohol sedimentation liquid all has inhibitory action to mouse knoting oil ear swelling and the swelling of rat yeast toes.
Chinese medicine Radix Polygoni Multiflori have Radix Polygoni Multiflori and Radix Polygoni Multiflori Preparata point, direct slicing is used as medicine for Radix Polygoni Multiflori, dries be used as medicine for Radix Polygoni Multiflori Preparata with Semen sojae atricolor liquor after mixing steaming.The function of the two is different: the removing toxic substances of Radix Polygoni Multiflori function, eliminating carbuncle, loosening bowel to relieve constipation, is usually used in treatment scrofula carbuncle sore, rubella pruritus, dryness of the intestine constipation; The invigorating the liver and kidney of Radix Polygoni Multiflori Preparata function, benefiting essence-blood, black beard and hair, bone and muscle strengthening, for blood deficiency and yellow complexion, vertigo and tinnitus, early whitening of beard and hair, soreness of the waist and knees, numb limbs and tense tendons, bleeding not during menses, chronic malaria body void etc.Radix Polygoni Multiflori Preparata of the present invention is the good merchantable brand of invigrating kidney.
Rhizoma Polygoni Cuspidati heat-clearing and toxic substances removing, promoting the function of the gallbladder to alleviate jaundice, expelling wind and removing dampness, dissipating blood stasis analgesic therapy, relieving cough and resolving phlegm.For arthralgia, jaundice due to damp-heat, amenorrhea, postnatal blood stasis does not Xia , WEIJIA, cough with copious phlegm, burn due to hot liquid or fire, traumatic injury, carbuncle sore tumefacting virus.Rhizoma Polygoni Cuspidati contains knotweed glycoside, organic acid, glycoside, polysaccharide etc.Having heat-clearing and toxic substances removing, cooling and heatstroke-eliminating, stomach invigorating food effect clearly, is a kind of polygonaceae plant.
The dry mature seed that Semen Cassiae (formal name used at school: CatsiatoraLinn) is pulse family annual herb plant Semen Cassiae or little Semen Cassiae.Semen Cassiae is also Semen Cassiae.Semen Cassiae is annual suffruticose draft; The brightly yellowish color of Semen Cassiae, pod is elongated, four prism type; Little Semen Cassiae plant is less, and pod is shorter, is one of important composition.Have the merit of improving eyesight fat-reducing with it and name it.Semen Cassiae bitter in the mouth, sweet, one-tenth, cold nature, enters liver, kidney, large intestine channel; Loosening bowel to relieve constipation, blood fat reducing improving eyesight, treatment constipation and hyperlipidemia, hypertension.Liver heat removing and eyesight improving, diuretic relieving constipation, has laxative action, reducing blood pressure and blood fat.
Stigma Maydis sweet in the mouth, light, property is put down.Return bladder, liver, gallbladder meridian.There is inducing diuresis to remove edema; Effect of liver heat removing function of gallbladder promoting.Main edema, dribbling urination, jaundice, cholecystitis, cholelithiasis, hypertension, diabetes, galactostasis." the southern regions of the Yunnan Province book on Chinese herbal medicine ": the wide intestinal therapeutic method to keep the adverse QI flowing downwards.Control married woman's breast knot, galactostasis, congestion and swelling pain, heating of being afraid of cold, headache body is stranded." south of the Five Ridges gather medicinal herbs record ": decoct soup with Carnis Sus domestica and control diabetes.Control again dribbling urination sandstone, bitter unbearably painful, decoct soup and be taken in small doses at short intervals." conventional glossary of Herbs and Drugs among the people ": can reduce blood pressure, inducing diuresis to remove edema.Control nose bleeding, redly to collapse." Traditional Chinese Medicine in Sichuan will ": clearing away heat from blood, diuresis.Harness the Yellow River subcutaneous ulcer, wind heat, eruption, spits blood and redly to collapse.
Fructus Gardeniae is Chinese medicine, belongs to the 1st batch of medicine-food two-purpose resource that Ministry of Public Health is promulgated, has the effects such as hepatoprotective, function of gallbladder promoting, blood pressure lowering, calmness, hemostasis, detumescence, is usually used in the diseases such as treatment icterohepatitis, bruise, hypertension, diabetes at tcm clinical practice.Cure mainly calentura vexed; Liver-fire conjunctival congestion; Headache; Jaundice due to damp-heat; Stranguria; Dysentery hematuria; Aphtha of the mouth and tongue; Sore swollen toxin; Sprain and swell and ache.This product has very large curative effect to conjunctival congestion and swelling pain.These product rush down clearly three burnt pathogenic heats, can treating the liver gallbladder burning hot on the conjunctival congestion and swelling pain of attacking, often join Radix Et Rhizoma Rhei use, as Fructus Gardeniae soup " Shengji Zonglu ".
Rhizoma Alismatis, nature and flavor: sweet, cold.Enter kidney, urinary bladder channel.Effect: diuretic, eliminating dampness by diuresis, expels the heat-evil.Control dysuria, edema distension, vomiting, dysentery, phlegm retention, beriberi, gonorrhea, hematuria." herbal classic ": main anemofrigid-damp arthralgia, breast is difficult, and disappear water, supports the five internal organs, physical strength profiting, fertile strong." not Lu ": tonifying deficiency five kinds of over strain, except the five internal organs feeling of fullness, plays cloudy gas, stopping leak essence, quenches one's thirst, drenches drop, cuts off the water by bladder, three Jiao." property of medicine opinion ": main essence of suffering from a deficiency of the kidney, from going out, controls five types of stranguria, sharp bladder heat, straight through water passage.
The root of Radix Scutellariae is used as medicine, bitter in the mouth, cold in nature, has heat clearing and damp drying, eliminating fire and detoxication, hemostasis, the effect such as antiabortive.Cure mainly the diseases such as epidemic febrile disease, upper respiratory tract infection, cough due to lung-heat, damp and hot jaundice, pneumonia, dysentery, hemoptysis, conjunctival congestion, frequent fetal movement, hypertension, carbuncle furuncle.The clinical antibiotic property of Radix Scutellariae is better than Rhizoma Coptidis, and does not develop immunity to drugs.
Folium Mori are dried leaves of moraceae plants Mulberry.Gather after first frost, removing impurity, drying and obtain, is a kind of wind-heat-dispersing medicinal, both oral administration, also can external application.It is cold in nature, sweet in the mouth, hardship, has effect of dispelling wind and heat pathogens, clearing away lung-heat and moistening for dryness, liver heat removing and eyesight improving, can treat anemopyretic cold, lung-heat type cough, dizziness headache, the disease that conjunctival congestion is dim-sighted.In modern times, doctor trained in Western medicine uses Folium Mori and Folium Mori biological preparation as the medicine improving diabetes and other various difficult miscellaneous diseases, thinks that its drug effect is very extensive.There are clearing away lung-heat and moistening for dryness, cough-relieving, reduce phlegm and internal heat, reduce phlegm, control night sweat; Tonifying liver, liver heat removing and eyesight improving, treatment dizziness and blurred vision, insomnia, elimination eye strain; Detumescence, purify the blood ' treatment dysentery, stomachache, fat-reducing, except beriberi, sharp large and small intestinal; Anti-stress, removing heat from blood, blood pressure lowering, blood fat reducing, prevention myocardial infarction, cerebral hemorrhage, dispel headache, long hair; Blood sugar lowering, anti-sugar are sick.
Herb Gynostemmae Pentaphylli Latin literary fame: Gynostemmapentaphyllum (Thunb.) Makino Cucurbitaceae, Gynostemma herbaceous stem Climbing Plant; Bitter in the mouth; Micro-sweet; Cool in nature.Return lung; Spleen; Kidney channel.Cure mainly: body void is weak; Nephrasthenia emission; Leukopenia; Hyperlipemia; Viral hepatitis; Chronic gastroenteritis; Chronic tracheitis.Replenishing QI to invigorate the spleen, preventing phlegm from forming and stopping coughing, heat-clearing and toxic substances removing.This kind is used as medicine, and has effect of eliminating inflammation and expelling toxin, eliminating phlegm and stopping cough.Herb Gynostemmae Pentaphylli is the most important, has following Chinese medicine characteristic: arrange in pairs or groups to boil water with Herb Gynostemmae Pentaphylli and Ganoderma or brew up, can treat hypertension, hyperlipidemia, hyperglycemia, the diseases such as fatty liver.There is effect of protecting liver and detoxication, blood pressure lowering, blood fat reducing blood glucose.It is gypenoside, Herb Gynostemmae Pentaphylli glucoside (polysaccharide), water-soluble amino acid, flavonoid, multivitamin, trace element, mineral etc. that Herb Gynostemmae Pentaphylli mainly contains effective constituent.
Herba Portulacae (Classification system: PortulacaoleraceaL.) is Portulacaceae annual herb plant.Plump succulence, without hair, high 10 ~ 30cm, is born in the area without shade such as roadside, field and ruins, flower garden.All there is distribution domestic various places.This kind is medicine food dual purpose plant.Herb hyoscine, has clearing away heat-damp and promoting diuresis, removing toxic substances and promoting subsidence of swelling, antiinflammatory, quenches the thirst, diuresis; Seed improving eyesight.Modern study, Herba Portulacae is also containing abundant SL3 fatty acid and vitamin A sample material.SL3 fatty acid forms cell membrane, especially brain cell membrane and the necessary material of eye cell membrane; Vitamin A sample substance maintains epithelial tissue as skin, cornea and conjunctival normal function, participates in the synthesis of rhodopsin, strengthens retinal photoreceptor performance, also participates in many oxidizing processs in body.
Containing flavone compound in Herba Taxilli leave: Quercetin (quercetin), quercitrin (quercitrin) and a small amount of dextrorotation catechol (catechol).Bitter sweet, flat.Enter liver, kidney channel.Invigorating the liver and kidney, bone and muscle strengthening, except rheumatism, the meridian dredging, beneficial blood, antiabortive.Control soreness of waist and knee joint, muscles and bones flaccidity is weak, hemiplegia, beriberi, anemofrigid-damp arthralgia, vaginal bleeding during pregnancy metrorrhagia, lack of lactation after delivery.Control chronic cough [3], protrusion of the tongue [4] is dizzy." herbal classic ": main lumbago, children's's stiffback, carbuncle, antiabortive, fill skin, hard, tooth, long man." not Lu ": main incised wound, goes numbness, woman's metrorrhagia, and internal injury is not enough, disease more than puerperal, lower milk." the southern regions of the Yunnan Province book on Chinese herbal medicine ": raw Sophora japonica L. person, cures mainly large intestine hematochezia, hemorrhoidal hamorrhage band blood, anal fistula.Raw mulberry person, controls bones and muscles pain, walks grain, anemofrigid-damp arthralgia.Pericarpium Zanthoxyli tree person, controls taste cold, the nauseating regurgitation of food from the stomach of vomiting; Again with controlling syphilitic skin lesions poison, first deficiency and coldness or metrorrhagia under married woman." book on Chinese herbal medicine covers bamboo fish trap ": loose skin infection, chases after rheumatism, but stiffback lumbago.
Thallus Laminariae (Thallus Eckloniae) is the medical herbs that " Chinese Pharmacopoeia " includes, and medicinal source is the dry thallus of Laminariaceae plant Thallus Laminariae (Thallus Eckloniae) or Alariaceae plant Thallus Laminariae (Thallus Eckloniae) (goose palm dish).Summer, Qiu Erji fish, and dry.Thallus Laminariae (Thallus Eckloniae) gas raw meat, taste becomes.Return liver, stomach, kidney channel.There is hard masses softening and resolving, expectorant, the function of diuretic.For phlegm retention edema.Hard masses softening and resolving, expectorant, diuretic.Goiter, scrofula, painful and swollen testis, phlegm retention edema.Become; Cold; Nontoxic.Return liver, stomach, kidney channel.Cure mainly eliminating phlegm and softening indurated mass; Diuretic detumescent.Main scrofula; Goiter; Dysphagic; (Epileptic is ruined) hernia beriberi edema.For goiter, scrofula, painful and swollen testis, phlegm retention edema." not Lu ": main 12 kinds of edema, the coalescent gas of goiter, flaccidity skin ulcer." property of medicine opinion ": dredging water passages, removes swelling of the face, removes malignant boil scrofula.Yao Kecheng " food book on Chinese herbal medicine ": Thallus Laminariae, main woman's leucorrhea with red and white discharge, man's essence lets out nocturnal emission.
Herba Artemisiae Scopariae is bitter, pungent, is slightly cold.Return spleen, stomach, liver, gallbladder meridian.Herba Artemisiae Scopariae clearing away heat-damp and promoting diuresis; Jaundice eliminating.Cure mainly: jaundice, dysuria, eczema pruritus, infectious jaundice type hepatitis etc.Pharmaceutical research has function of gallbladder promoting, liver function protecting, antipyretic, antiinflammatory, blood fat reducing, blood pressure lowering, the effects such as coronary dilating.
Herba Violae taste bitter, acrid, cold.GUIXIN, lung meridian.Have heat-clearing and toxic substances removing, removing heat from blood is subsided a swelling, and the effect of clearing away heat-damp and promoting diuresis, cures mainly furuncle, carbuncle, scrofula, jaundice, dysentery, diarrhoea, conjunctival congestion, sore throat, venom.All various furunculosis carbuncle skin ulcers, red and swollen heat pain person, alone fresh goods can smash juice clothes, and apply affected part with its slag; Or with Flos Lonicerae, Herba Taraxaci, Flos Chrysanthemi Indici compatibility.If deficiency of qi and blood person, Radix Angelicae Sinensis, the Radix Astragali can be added; If the swollen person of damp and hot condensation bone carbuncle pain height, can with Poria, Semen Plantaginis, Flos Lonicerae, the same use of Radix Achyranthis Bidentatae, in order to damp and clearing heat.
Herba Portulacae Grandiflorae (formal name used at school: ScutellariabarbataD.Don) all herbal medicine, has heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, the function such as anticancer.Sour in the mouth cold in nature, herb is containing compositions such as multivitamin, trace element and aminoacid.There is removing pathogenic heat from blood and toxic substance from the body, eliminating stasis to stop pain, effect of detumescence and clearing away heat-damp and promoting diuresis.Function cures mainly: have heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, anticancer effect; Appendicitis curing, hepatitis, stomachache, early hepatocarcinoma, pulmonary carcinoma, cervical cancer, mastitis etc.; External is controlled pain furuncle and is treated, the diseases such as treating swelling and pain by traumatic injury.This medicine large usage quantity among the people." figure will planted by Guangxi medicine ": antiinflammatory, dissipating blood stasis stops blooding.Control traumatic injury and injure dysentery." Nanning City's medicine will ": reducing swelling and alleviating pain.Control traumatic injury knife injury and skin infection." Quanzhou book on Chinese herbal medicine ": dredging collateral, heat-clearing and toxic substances removing, dispel the wind loose blood, promoting the circulation of QI to induce diuresis, removing blood stasis with potent drugs pain relieving.Main stranguria with blood for oral administration, spits blood, epistaxis; Venom is controlled in external, carbuncle, furuncle, innominate toxic swelling.
Radix Semiaquilegiae, formal name used at school: BegoniafimbristipulaHance, herb people medicine, has removing toxic substances, cough-relieving, the effect of invigorating blood circulation, subsiding a swelling.
Fructus Crataegi stone fruit, caryoplasm is hard, and sarcocarp is thin, and taste is micro-sour and astringent.Fruit is raw-eaten or make preserved fruit fruitcake, can be used as medicine after drying, Chinese distinctive medicine fruit dual-purpose seeds, there is the effects such as blood fat reducing, blood pressure, heart tonifying, arrhythmia, also be simultaneously the good medicine of spleen benefiting and stimulating the appetite, relieving dyspepsia, phlegm reduction of blood circulation promoting, the disease such as, hernia, blood stasis full to chest and diaphragm spleen, amenorrhea has good curative effect.Flavone compound vitexin in Fructus Crataegi is the medicine that a kind of antitumaous effect is stronger, and its extract all has certain effect to growth of cancer cells, propagation and infiltration metastasis in suppression body.
Specific embodiment 1:
Gather when 6-8 Spica Prunellae in middle of the month fruit ear is brownish red, removing impurity, dries, and raw use, Jiang Qipao enters ethanol extraction or extraction.
Again by all the other raw material Stigma Maydis, Radix Semiaquilegiae, Herba Taxilli, Semen Cassiae, Herb Gynostemmae Pentaphylli, Folium Mori, Herba Portulacae, Thallus Laminariae (Thallus Eckloniae), Radix Polygoni Multiflori Preparata, Rhizoma Polygoni Cuspidati, Fructus Crataegi, Radix Scutellariae, Herba Scutellariae Barbatae, Rhizoma Alismatis, Herba Artemisiae Scopariae, Fructus Gardeniae, Herba Violae, pulverizes, and extracting solution is made in extraction or extraction.
Two kinds of extract mixing, ultraviolet radiation for sterilizing and disinfecting is bottled.
Specific embodiment 2:
Gather when 6-8 Spica Prunellae in middle of the month fruit ear is brownish red, removing impurity, dries, raw use, general 5000g, steeped in the ethanol of 5-10 times amount after roguing chopping, medicated powder is equipped with in lid stainless steel cask, adds 70% ethanol, quality is 0.8-1 times of coarse powder, stir, moistening airtight placement more than 1 hour, makes abundant expansion; Drug sample after moistening expansion is mixed pine by filter plate gauze bag parcel again bottom percolator after paving does loose, then powder is contained with rustless steel spoon, uniform loading percolator, dress 10-12 cm thick, even by T-bar pressure, then press aforesaid operations, loading in layer, suitable pressurization, medicated powder must not load 2/3 eminence exceeding percolator; Medicated powder face upper cover rustless steel orifice plate fastens, and opens the baiting valve below percolator, and puts a container, then slowly add 70% ethanol; Air between medicated powder powder to be discharged, and have ethanol to flow out about about 20L, close baiting valve, cover cylinder of filtering, dipping 24 hours, then open baiting valve and carry out percolation, control percolation speed and be generally 1000g medical material outflow 2 ~ 3ml per minute, filtrate puts into liquid container, and pours ethanol time emptying into liquid container; Percolate is merged and leaves standstill.
Get other raw materials more again by all the other raw material Stigma Maydis 1500g, Radix Semiaquilegiae 1500g, Herba Taxilli 1500g, Semen Cassiae 1500g, Herb Gynostemmae Pentaphylli 1500g, Folium Mori 1500g, Herba Portulacae 1500g, Thallus Laminariae (Thallus Eckloniae) 1500g, Radix Polygoni Multiflori Preparata 1500g, Rhizoma Polygoni Cuspidati 1500g, Fructus Crataegi 1500g, Radix Scutellariae 1500g, Herba Scutellariae Barbatae 1500g, Rhizoma Alismatis 1500g, Herba Artemisiae Scopariae 1500g, Fructus Gardeniae 1500g, Herba Violae 1500g, cleans and dries, in 70 DEG C of baking ovens, dry 8-12h, take out and be placed in cooling in drying baker, pulverized 80-100 mesh sieve with pulverizer; To be soaked the particulate matter that sieves in water 12 hours, then put into extraction pot heated and boiled 1 hour, filter, filtrate is for subsequent use; Filtering residue adds water, and second time heating, boils 45 minutes, and filter, filtrate is for subsequent use; Filtering residue adds water again, and heated and boiled half an hour third time, filter, heating is concentrated into paste, stand for standby use.Paste extract is placed in 70-90% ethanol and soaks 1-2 hour, in water-bath, be heated to 60 DEG C-70 DEG C, lixiviate 2h, every 10min stirs once, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, merge lixiviating solution, be condensed into pasty state filtrate
Merged by above-mentioned two kinds of extracting solution and insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C, relative density is the concentrated solution of 1.25, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.1g crude drug amount, then adds dextrin, bottle after ultraviolet sterilization.
Specific embodiment 3:
Gather when 6-8 Spica Prunellae in middle of the month fruit ear is brownish red, removing impurity, dries, raw use, general 4500g.80-100 mesh sieve was pulverized with pulverizer; To be soaked the particulate matter that sieves in water 12 hours, then put into extraction pot heated and boiled 1 hour, filter, filtrate is for subsequent use; Filtering residue adds water, and second time heating, boils 45 minutes, and filter, filtrate is for subsequent use; Filtering residue adds water again, and heated and boiled half an hour third time, filter, heating is concentrated into paste, stand for standby use.Paste extract is placed in 70-90% ethanol and soaks 1-2 hour, in water-bath, be heated to 60 DEG C-70 DEG C, lixiviate 2h, every 10min stirs once, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, merge lixiviating solution, be condensed into pasty state filtrate, stand-by.
Get other raw materials more again by all the other raw material Stigma Maydis 1100g, Radix Semiaquilegiae 1200g, Herba Taxilli 1100g, Semen Cassiae 1200g, Herb Gynostemmae Pentaphylli 1100g, Folium Mori 1200g, Herba Portulacae 1100g, Thallus Laminariae (Thallus Eckloniae) 1200g, Radix Polygoni Multiflori Preparata 1100g, Rhizoma Polygoni Cuspidati 1100g, Fructus Crataegi 1100g, Radix Scutellariae 1100g, Herba Scutellariae Barbatae 1100g, Rhizoma Alismatis 1100g, Herba Artemisiae Scopariae 1100g, Fructus Gardeniae 1200g, Herba Violae 1100g, get other raw materials and clean roguing, steep in the ethanol of 5-10 times amount, medicated powder is equipped with in lid stainless steel cask, add 70% ethanol, quality is 0.8-1 times of coarse powder, stir, moistening airtight placement more than 1 hour, make abundant expansion, drug sample after moistening expansion is mixed pine by filter plate gauze bag parcel again bottom percolator after paving does loose, then powder is contained with rustless steel spoon, uniform loading percolator, dress 10-12 cm thick, even by T-bar pressure, then press aforesaid operations, loading in layer, suitable pressurization, medicated powder must not load 2/3 eminence exceeding percolator, medicated powder face upper cover rustless steel orifice plate fastens, and opens the baiting valve below percolator, and puts a container, then slowly add 70% ethanol, air between medicated powder powder to be discharged, and have ethanol to flow out about about 20L, close baiting valve, cover cylinder of filtering, dipping 24 hours, then open baiting valve and carry out percolation, control percolation speed and be generally 1000g medical material outflow 2 ~ 3ml per minute, filtrate puts into liquid container, and pours ethanol time emptying into liquid container, percolate is merged and leaves standstill.
Insert in economic benefits and social benefits vacuum concentrator for two kinds that above-mentioned steps are obtained, when being concentrated into 90 DEG C, relative density is the concentrated solution of 1.05, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.1g crude drug amount; Then add dextrin, bottle after ultraviolet sterilization.
Pharmacological toxicity is tested
Experimental example 1: acute toxicity test of the present invention
One, test material: animal: Kunming mouse, body weight 18-25g, male and female half and half, Shandong University's biology laboratory breeding.Medicine: the present invention's (all raw material mixing decoction 2 times merges and filters, taking liquid) is containing 0.0365mg/ml.
Two, method:
1, LD50 calculates: adopt improvement karber's method, mice is divided into 5 groups at random, often organize 10, male and female half and half, dissolve adding distil water of the present invention, are made into Cmax, by the administration of mice maximum permission capacity, institute is followed successively by 18,14.4 to dosage by crude drug amount, 11.5,9.2,7.4 (g.kg-1), in animal fasting (can't help water) after 18 hours, administration at twice in one day (interval half an hour), each 0.5ml, observes animal dead situation.
2, maximum tolerated dose measures (MTD value): get mice 20, each 10 of male and female.Adding distil water of the present invention is dissolved, is made into maximum concentration, by the maximum tolerated dose of animal, feed device and can twitch to inject to fill with and be as the criterion.In animal fasting (can't help water) after 18 hours, administration at twice in one day (interval half an hour), each 0.5ml (every ml containing crude drug 0.36g), total dose is 18g crude drug/kg.d, 300 times of quite clinical adult 50Kg body weight consumption.Continuous Observation 7 days after administration.
Three, result of the test:
In LD50 calculates when giving mice with maximum acceptable concentration and maximum permission capacity (18g/Kg.d), have no dead mouse, namely LD50 is not measured, ask maximum tolerated dose only, in 7 day observation period, its appetite of animal, activity, hair color, the mental status etc. are all normal, grow normal, there are no death.Namely select the 300 times of doses being equivalent to clinical dosage, and have no adverse reaction, show that acute toxicity is minimum, MTD > 18g/Kg.d.
Experimental example 2: the result of the test of acute toxicity and long term toxicity
Acute toxicity test: give the present invention by the disposable gavage of white mice, maximum concentration 35%, maximum gavage capacity 0.4ml/10g, dosage 14g/kg (every g medicated powder is equivalent to 10g crude drug), Continuous Observation 7 days, do not find any toxic reaction, because concentration and dosage cannot increase, therefore fail to measure the LD50 of this medicine.Maximum tolerance determination: with maximum concentration, maximum gavage capacity, mice lavage administration 3 times, 5 hours, interval, then Continuous Observation 7 days, none example is dead.Medicated powder dosage is > 42g/kg. day (every g medicated powder is equivalent to 10g crude drug), calculates 420 times of the clinical consumption per day that is equivalent to be grown up by kg body weight.
Long term toxicity test: whether produce toxic reaction for observing long-term prescription, give rat the present invention respectively and raise clothes, by adult 70 times of clinical consumption per day and 35 times (i.e. 7g/kg/ day and 3.5g/kg/ day), give continuously and feed 8 weeks, have no the behavior of rat, feed, body weight appearance extremely, with matched group ratio, routine blood test, hepatic and renal function, the change all without exception of various important organ, within the scope of institute's dosage, do not find any toxicity of the present invention.Confirmed by the acute and chronic toxicity test of animal, safety range of the present invention is comparatively large, is a kind of safe and reliable health product.
Pharmacological experiment:
Hypertension is the risk factor causing cardiovascular and cerebrovascular disease important, is the modal chronic disease of global human, and actively preventing and treating hypertension is extensively concerned important topic.Hypertensive pathogenesis is complicated, illustrates not yet completely so far.In recent years, the non-selective cation channel on a kind of cell membrane, transient receptor potential channel C subfamily (transientreceptorpotentialcanonical, TRPC) and hypertensive mutual relation are just becoming the focus of research.TRPC channel organization is widely distributed, regulates by many factors, wide participation cardiovascular pathology physiological process.Research finds, transient receptor potential channel C subtribe 3 hypotype (TRPC3) and 6 hypotypes (TRPC6) are close with Relationship between Essential Hypertension, mechanism of action and the traditional pathogenesis of hypertension distinct.But, at present about the research of antihypertensive drugs to TRPC pass effect just just starts.This research is intended to understand spontaneous hypertensive rat (spontaneouslyhypertensiverats, SHR) expression of aorta TRPC3 and TRPC6, after the present invention, valsartan and amlodipine in treatment SHR rat, observe change expressed by medicine impact on TRPC3 and TRPC6, Primary Study TRPC3 and TRPC6 regulates and controls the mechanism of blood pressure, finds better therapy target provide experimental basis for clinical prevention hypertension.
1 materials and methods
1.1 material
1.1.1 laboratory animal
Healthy SHR and WKY rat, 12 weeks, male, body weight 240-280g, purchased from institute of lab animals of China Concord Medical Science University of the Chinese Academy of Medical Sciences, licence numbering SCXK (capital) 2009-0004, raises in Shandong Medical University's Experimental Animal Center.
1.1.2 main agents and preparation thereof
(1) main agents
Valsartan (DAIWEN) Nova Lab SDN. BHD of ramipril (Rui Tai) Sanofi-Aventis pharmaceutical Co. Ltd Amlodipine Besylate Tablet (Norvasc) pfizer inc TRPC3, TRPC6 Tu Kang polyclonal antibody U.S. Chemicon company's T rizolReagent American I nvitrogen Reverse Transcription box ReverTraAce-α-Japanese TOYOBO Membrane protein extraction test kit shellfish is won Bo Aosen Bioisystech Co., Ltd BCA determination of protein concentration test kit Beijing, biological company limited GAPDH rabbit anti-monoclonal antibody Beijing Bo Aosen Bioisystech Co., Ltd Radix Cochleariae officinalis enzyme labelling goat anti-rabbit igg Beijing Bo Aosen Bioisystech Co., Ltd SDS-PAGE gel and prepares test kit Beijing Bo Aosen Bioisystech Co., Ltd
(2) preparation of main agents
4% paraformaldehyde: paraformaldehyde 40g, 1L protein electrophoresis buffer is settled to: Tris6.0g with 0.1MPBS buffer, glycine 28.8g, SDS1.0g, 1L transferring film buffer is settled to: Tris2.375g with deionized water, glycine 11.25g, SDS0.375g, methanol 200ml, deionized water is settled to 1LTBS buffer: NaCl8.0g, KCl0.2g, Tris3.0g, distilled water is settled to 1LTBST buffer: TBS buffer 700ml, 20% tween 20 1.65ml confining liquid: defatted milk powder 5g, TBST (0.01%) 100ml.
1.1.3 key instrument and equipment
Rat tail artery non-invasive blood pressure measuring RBP-1 type, Huaibei Zheng Hua bio-instruments company limited High speed refrigerated centrifuge Allegra64R type, U.S. Beckman inverted microscope Japan OLYMPUS gel/luminescence image analysis system ChemiDOC-X-RS type, U.S. Bio-Rad ultra-pure water instrument ELIX10 type, U.S. Minipore grads PCR instrument S1000 double flute, the long microplate reader MSS type of U.S.'s Bio-Rad all-wave, Finland's thunder vigorous ultra cold storage freezer MDF-382HT type, Japan Sanyo micro centrifuge Micro17 type, U.S. Thermo, electronic analytical balance AUW120D type, Japan's Shimadzu, three use electric heat constant temp. water tank KW-1000DA type, Community of Jin Tan County city gold is experimental apparatus factory.Autoclave LAC-5060S type, Korea S's Lay is rich carries relaxation constant-temperature table 420 class, U.S. Thermo electric heating constant-temperature blowing drying box DHG-9140A type, Shanghai Qi Xin scientific instrument company limited.Electrophresis apparatus DYY-10C type, Beijing Liuyi Instrument Factory's Vertial electrophorestic tank.U.S. Bio-Rad Desk type refrigeration constant-temperatureoscillator shaking table SHA-2 type, Community of Jin Tan County city gold is experimental apparatus factory.722 ultraviolet light spectrophotometer UV-265 types, Japanese Shimadzu
1.2 experimental technique
1.2.1 animal grouping and administration
24 12 week ages, healthy male SHR rat, was divided into 4 groups (n=6): SHR matched group, of the present invention group, valsartan group and amlodipine group at random.6 12 week age male WKY rat be set to Normal group,
Totally 5 groups.Medication therapy groups uses the present invention (1mg/kgd respectively, the present invention extracts former medicine and is dissolved in normal saline), valsartan (30mg/kgd, the former medicine of valsartan is dissolved in normal saline), amlodipine (5mg/kgd, the former medicine of Amlodipine Besylate Tablet is dissolved in normal saline) gavage 4 weeks.WKY matched group, SHR matched group give normal saline gavage 4 weeks.
1.2.2 animal blood pressure measures
Rat systolic pressure before and after Drug therapy is measured with tail cover method analysis of blood pressure device.Rat, under waking state, is placed in 38 DEG C of calorstats after 10 minutes, is fixed in measure case, and Mus tail is through tail cover; To tail cover inflating pressure after its peace and quiet, make pulse wave be decreased to disappearance gradually, be then deflated to pulse wave and recover normal completely.Systolic pressure is pressure value corresponding when again there is waveform after pulse blocks, and every repeated measure 3 times, averages.
1.2.3 sacrifice of animal and collection of specimens
Rat with after the intraperitoneal anesthesia of 40mg/100g dosage, is fixed on operating board with 3.5% chloral hydrate, opens breast and takes out aorta (from aortic arch to abdominal aortic bifurcation).Bloodstain is cleaned with the sterilizing DEPC water of 4 DEG C of pre-coolings.Choose the relatively-stationary position of thoracic aorta epimere and be about 7mm, specimen is put into 4% paraformaldehyde and fix, make vascular tissue's paraffin section, for Immunohistochemical detection.All the other specimen are cut into fritter and put into cryopreservation tube, in liquid nitrogen after frozen 30min, are transferred to-80 DEG C of Refrigerator stores, detect for RT-PCR, Westernblot.DEPC water sterilization enzyme inactivation all used by all experiment appliances, vessel.
1.3 statistical procedures
All data all adopt SAS9.1.3 statistical software to analyze, measurement data represents with mean ± standard deviation (x ± s), between group, mean compares employing variance analysis, and each group is compared between two and use Bonferroni method, and P < 0.05 has statistical significance for difference.
2 results
2.1 blood pressure
SHR matched group blood pressure is apparently higher than WKY matched group (P < 0.05); Drug therapy is after 4 weeks, and the blood pressure of the present invention, valsartan group and amlodipine group obviously reduces, and has statistical significance (P < 0.05) with self comparing before SHR matched group and Drug therapy; But of the present invention group, difference of blood pressure not statistically significant between valsartan group and amlodipine group group.(referring to table 1)
Each group rat systolic pressure (SBP) change (x ± s) before and after table 1 Drug therapy
Note: ★ p < 0.05vs is with WKY matched group in age in week; ▲ p < 0.05vsSHR matched group (16 weeks); ● p < 0.05vs is with before group treatment.
Discuss:
Chinese medicine Blood-pressure-lowerhealth-care health-care oral liquid of the present invention solves hypertension problem from basic, is that temporary the reducing blood pressure of blood vessel dilating improves symptom, the mechanism of blood pressure lowering of the present invention: fat eliminating unlike Western medicine, promote blood circulation, vessel softening, diuresis, toxin expelling, decompression is that the basic reason produced from hypertension is started with, blood pressure lowering is very lasting, and, the dizziness that the Western medicine simultaneously can also eliminating hypertension and blood pressure lowering brings, headache, feel sick, inappetence, edema etc. are not disease symptoms.Chinese medicine health-care oral liquid blood pressure lowering curative effect is lasting, and safety is reliably, nontoxic, is worth promoting.
The triterpene saponin that it is aglycon that Spica Prunellae herb contains with oleanolic acid (Oleanolicacid).Still containing the glycoside material such as rutin (Rutin), hyperin (Hyperoside). also containing organic acid such as ursolic acid (Ursolicacid), caffeic acid (Caffeicacid) and free oleanolic acids. still containing inorganic salts such as vitamin B1, vitamin C, vitamin K, carotene, resin, amaroid, tannin, volatile oil, alkaloid and potassium chloride.The water-leach liquor of modern study Spica Prunellae, ethanol water-leach liquor and 30% ethanol extraction, to anesthetized animal lumbar injection, intravenous injection or the oral effect that all reduces blood pressure, intravenous injection hypotensive effect is obvious, oral administration then hypotensive effect is faint. and decoct (100mg/kg) is injected in anesthetized dog, significantly lasting hypotensive effect can be produced, but there is tachylaxis, after vagotomy, its hypotensive effect obviously weakens. to renal hypertension dog, after taking medicine continuously 2 weeks, blood pressure has moderate reduction, returns to again originally level after drug withdrawal.Spica Prunellae stem, leaf, fringe and herb all have hypotensive effect, and the effect of fringe is more weak.
Claims (10)
1. the Spica Prunellae health care oral liquid of a hypertension and hyperlipemia, it is characterized in that, described Spica Prunellae health care oral liquid comprises the raw material of following parts by weight: Spica Prunellae 10 ~ 50 parts, Stigma Maydis 10 ~ 20 parts, Radix Semiaquilegiae 10 ~ 20 parts, Herba Taxilli 10 ~ 20 parts, Semen Cassiae 10 ~ 20 parts, Herb Gynostemmae Pentaphylli 10 ~ 20 parts, 10 ~ 20 parts, Folium Mori, Herba Portulacae 10 ~ 20 parts, Thallus Laminariae (Thallus Eckloniae) 10 ~ 20 parts, Radix Polygoni Multiflori Preparata 10 ~ 20 parts, Rhizoma Polygoni Cuspidati 10 ~ 20 parts, Fructus Crataegi 10 ~ 20 parts, Radix Scutellariae 10 ~ 20 parts, Herba Scutellariae Barbatae 10 ~ 20 parts, Rhizoma Alismatis 10 ~ 20 parts, Herba Artemisiae Scopariae 10 ~ 20 parts, Fructus Gardeniae 10 ~ 20 parts, Herba Violae 10 ~ 20 parts.
2. the Spica Prunellae health care oral liquid of hypertension and hyperlipemia according to claim 1, it is characterized in that, described Spica Prunellae health care oral liquid comprises the raw material of following parts by weight: Spica Prunellae 10 ~ 30 parts, Stigma Maydis 10 ~ 15 parts, Radix Semiaquilegiae 10 ~ 15 parts, Herba Taxilli 10 ~ 15 parts, Semen Cassiae 10 ~ 15 parts, Herb Gynostemmae Pentaphylli 10 ~ 15 parts, 10 ~ 15 parts, Folium Mori, Herba Portulacae 10 ~ 15 parts, Thallus Laminariae (Thallus Eckloniae) 10 ~ 15 parts, Radix Polygoni Multiflori Preparata 10 ~ 15 parts, Rhizoma Polygoni Cuspidati 10 ~ 20 parts, Fructus Crataegi 10 ~ 20 parts, Radix Scutellariae 10 ~ 20 parts, Herba Scutellariae Barbatae 10 ~ 20 parts, Rhizoma Alismatis 10 ~ 20 parts, Herba Artemisiae Scopariae 10 ~ 20 parts, Fructus Gardeniae 10 ~ 20 parts, Herba Violae 10 ~ 20 parts.
3. the Spica Prunellae health care oral liquid of hypertension and hyperlipemia according to claim 1, it is characterized in that, described Spica Prunellae health care oral liquid comprises the raw material of following parts by weight: Spica Prunellae 10 ~ 50 parts, Stigma Maydis 10 ~ 20 parts, Radix Semiaquilegiae 10 ~ 20 parts, Herba Taxilli 10 ~ 20 parts, Semen Cassiae 10 ~ 20 parts, Herb Gynostemmae Pentaphylli 10 ~ 20 parts, 10 ~ 20 parts, Folium Mori, Herba Portulacae 10 ~ 20 parts, Thallus Laminariae (Thallus Eckloniae) 10 ~ 20 parts, Radix Polygoni Multiflori Preparata 10 ~ 20 parts, Rhizoma Polygoni Cuspidati 10 ~ 15 parts, Fructus Crataegi 10 ~ 15 parts, Radix Scutellariae 10 ~ 15 parts, Herba Scutellariae Barbatae 10 ~ 15 parts, Rhizoma Alismatis 10 ~ 15 parts, Herba Artemisiae Scopariae 10 ~ 15 parts, Fructus Gardeniae 10 ~ 15 parts, Herba Violae 10 ~ 15 parts.
4. the preparation method of the Spica Prunellae health care oral liquid of hypertension and hyperlipemia as described in any one of claims 1 to 3 item, it is characterized in that, the preparation process of described Spica Prunellae health care oral liquid comprises following aspect:
A. gather when Spica Prunellae fruit ear is brownish red when summer, removing impurity, dries, raw use;
B. the Spica Prunellae dried is pulverized, soaked ethanol heating extraction;
C. by other raw material pulverizing described, immersion ethanol extraction;
D. mixed by other raw material extracting solution concentrated with the Spica Prunellae extracting solution prepared, sterilizing is prepared into oral solutions.
5. the preparation method of the Spica Prunellae health care oral liquid of hypertension and hyperlipemia according to claim 4, is characterized in that, in described step a, between the 6-8 month, when Spica Prunellae fruit ear is brownish red, plucks, dry in the sun, allows it parch, for subsequent use.
6. the preparation method of the Spica Prunellae health care oral liquid of hypertension and hyperlipemia according to claim 4, is characterized in that, in described step b, Spica Prunellae chopping is placed in 70-90% ethanol and soaks 1-2 hour, in water-bath, be heated to 60 DEG C-70 DEG C, lixiviate 2h, every 10min stirs once, by filtered through gauze, adds 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, every 10min stirs once, filtered through gauze, merges lixiviating solution, be condensed into pasty state filtrate, stand-by.
7. the preparation method of the Spica Prunellae health care oral liquid of hypertension and hyperlipemia according to claim 4, is characterized in that, in described step c, all the other raw materials are cleaned roguing, put into 10 times amount ethanol, soak 1-2 hour, heating extraction 2 times, each 1-2 hour, remove supernatant, merge extractive liquid, 100-120 order filters, be the ultrafiltration post ultrafiltration of 5000-10000 again through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.05 filtrate.
8. the preparation method of the Spica Prunellae health care oral liquid of hypertension and hyperlipemia according to claim 4, it is characterized in that, in described steps d, two kinds of extracting solution are inserted in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C, relative density is the concentrated solution of 1.25, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.1g crude drug amount, bottles after ultraviolet ray sterilization bactericidal.
9. the preparation method of the Spica Prunellae health care oral liquid of hypertension and hyperlipemia according to any one of claims 1 to 3, it is characterized in that, the preparation process of described Spica Prunellae health care oral liquid comprises following aspect:
A. gather when Spica Prunellae fruit ear is brownish red when summer, removing impurity, dries, raw use;
B. the Spica Prunellae dried pulverizing, immersion ethanol are added extraction heat;
C. by other raw material pulverizing described, immersion ethanol extraction;
D. mixed by other raw material extracting solution concentrated with the Spica Prunellae extracting solution prepared, sterilizing is prepared into oral solutions.
10. the preparation method of the Spica Prunellae health care oral liquid of hypertension and hyperlipemia according to claim 9, it is characterized in that, in described step b, the extraction step of Spica Prunellae is: get Spica Prunellae chopping for subsequent use, steep in the ethanol of 5-10 times amount, medicated powder is equipped with in lid stainless steel cask, add 70% ethanol, quality is 0.8-1 times of coarse powder, stirs, moistening airtight placement more than 1 hour, makes abundant expansion; Drug sample after moistening expansion is mixed pine by filter plate gauze bag parcel again bottom percolator after paving does loose, then powder is contained with rustless steel spoon, uniform loading percolator, dress 10-12 cm thick, even by T-bar pressure, then press aforesaid operations, loading in layer, suitable pressurization, medicated powder must not load 2/3 eminence exceeding percolator; Medicated powder face upper cover rustless steel orifice plate fastens, and opens the baiting valve below percolator, and puts a container, then slowly add 70% ethanol; Air between medicated powder powder to be discharged, and have ethanol to flow out about about 20L, close baiting valve, cover cylinder of filtering, dipping 24 hours, then open baiting valve and carry out percolation, control percolation speed and be generally 1000g medical material outflow 2 ~ 3ml per minute, filtrate puts into liquid container, and pours ethanol time emptying into liquid container; Percolate is merged and leaves standstill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510755500.0A CN105343593A (en) | 2015-11-09 | 2015-11-09 | Spica prunellae health oral liquid capable of decreasing blood pressure and blood lipid as well as preparation method of spica prunellae health oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510755500.0A CN105343593A (en) | 2015-11-09 | 2015-11-09 | Spica prunellae health oral liquid capable of decreasing blood pressure and blood lipid as well as preparation method of spica prunellae health oral liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105343593A true CN105343593A (en) | 2016-02-24 |
Family
ID=55319752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510755500.0A Pending CN105343593A (en) | 2015-11-09 | 2015-11-09 | Spica prunellae health oral liquid capable of decreasing blood pressure and blood lipid as well as preparation method of spica prunellae health oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105343593A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105707321A (en) * | 2016-03-28 | 2016-06-29 | 济南高瑞生物科技有限公司 | Fat reducing tea |
| CN105816699A (en) * | 2016-03-25 | 2016-08-03 | 广西大学 | Sparassis crispa healthcare oral liquid with lipid and pressure reducing effects and preparation method thereof |
| CN108354040A (en) * | 2017-12-31 | 2018-08-03 | 李闯 | Cape jasmine kelp solid beverage and preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001199996A (en) * | 2000-01-24 | 2001-07-24 | Pola Chem Ind Inc | ACYL-CoA CHOLESTERYL ACYLTRANSFERASE INHIBITOR AND COMPOSITION COMPRISING THE SAME FOR HYPERLIPIDEMIA |
| CN104206594A (en) * | 2014-08-27 | 2014-12-17 | 青岛恒波仪器有限公司 | Herba Taxilli health-care tea capable of lowering blood pressure and blood lipid and preparation method thereof |
-
2015
- 2015-11-09 CN CN201510755500.0A patent/CN105343593A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001199996A (en) * | 2000-01-24 | 2001-07-24 | Pola Chem Ind Inc | ACYL-CoA CHOLESTERYL ACYLTRANSFERASE INHIBITOR AND COMPOSITION COMPRISING THE SAME FOR HYPERLIPIDEMIA |
| CN104206594A (en) * | 2014-08-27 | 2014-12-17 | 青岛恒波仪器有限公司 | Herba Taxilli health-care tea capable of lowering blood pressure and blood lipid and preparation method thereof |
Non-Patent Citations (6)
| Title |
|---|
| 岳桂华等: "《名老中医用药心得 第2辑》", 28 February 2013, 人民军医出版社 * |
| 张恩虎: "《实用临床中药手册》", 31 January 2001, 人民军医出版社 * |
| 柴瑞震: "《吃对食物,降压降脂两不误》", 30 April 2014, 中国轻工业出版社 * |
| 王松华: "双清片薄层色谱鉴别", 《中国药师》 * |
| 肇庆市端州区地方志编纂委员会: "《肇庆市志》", 31 October 1996, 广东人民出版社 * |
| 顾宁等: "《高血压病中医特色疗法》", 30 June 2012, 人民军医出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105816699A (en) * | 2016-03-25 | 2016-08-03 | 广西大学 | Sparassis crispa healthcare oral liquid with lipid and pressure reducing effects and preparation method thereof |
| CN105707321A (en) * | 2016-03-28 | 2016-06-29 | 济南高瑞生物科技有限公司 | Fat reducing tea |
| CN108354040A (en) * | 2017-12-31 | 2018-08-03 | 李闯 | Cape jasmine kelp solid beverage and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988638B (en) | Cyclocarya paliurus blood-lipid and blood-sugar reducing health-care tea and preparation method thereof | |
| CN102784363B (en) | Traditional Chinese medicine composition for treating pancreatic cancer and preparation method thereof | |
| CN104435775A (en) | Chinese medicinal health-care spirit and preparation method thereof | |
| CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
| CN106310120A (en) | Wide-spectrum traditional Chinese medicine composition water agent and preparation method thereof | |
| CN104208302A (en) | Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof | |
| CN103041208B (en) | Chinese herbal preparation for treating climacteric syndrome of women, and preparation method thereof | |
| CN104305205B (en) | A kind of Semen Cuscutae oral liquid improving immunity and preparation method thereof | |
| CN104206594A (en) | Herba Taxilli health-care tea capable of lowering blood pressure and blood lipid and preparation method thereof | |
| CN104958607A (en) | Traditional Chinese medicine composition for treating burning mouth syndromes of climacteric women and preparation method thereof | |
| CN108277138A (en) | A kind of health-care and nutritious wine and preparation method thereof | |
| CN105124078A (en) | Gardenia blood-glucose-reducing and lipid-reducing healthcare tea and preparing method thereof | |
| CN105194421A (en) | Self-heal health-care oral solution capable of reducing blood fat and preparation method thereof | |
| CN105497816A (en) | Traditional Chinese medicine preparation for treating atherosclerosis and preparation method thereof | |
| CN105343593A (en) | Spica prunellae health oral liquid capable of decreasing blood pressure and blood lipid as well as preparation method of spica prunellae health oral liquid | |
| CN102178781B (en) | Chinese medicine composition for treating scrotum eczema and preparation method thereof | |
| CN103933538A (en) | Medicine for treating spleen-kidney yang deficiency type cirrhosis ascites and preparation method thereof | |
| CN105211441A (en) | Red sage root leaf health-care tea of a kind of hypertension and hyperlipemia and preparation method thereof | |
| CN105341944A (en) | Salvia miltiorrhiza oral liquid for improving immunity and preparation method thereof | |
| CN105012873A (en) | Health-care blood-fat-lowering evening primrose oral liquid and preparation method thereof | |
| CN105056103A (en) | Steamed buns with assistant effect of reducing blood fat and cholesterol and processing method of steamed buns | |
| CN104888158A (en) | Folium apocyni veneti oral liquid for enhancing immunity and preparation method thereof | |
| CN105343502A (en) | Health-care oral liquid capable of improving immunity | |
| CN105343516A (en) | Selfheal oral liquid for treating liver-fire flaming and preparation method of oral liquid | |
| CN105233056A (en) | Rhubarb oral liquid capable of clearing away heat and removing dampness and beneficial to choleresis and detoxification and preparation method of rhubarb oral liquid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160224 |
|
| RJ01 | Rejection of invention patent application after publication |